Literature DB >> 23575073

Morphological profile and receptor status in breast carcinoma: an institutional study.

Chandrika Rao1, Jayaprakash Shetty, H L Kishan Prasad.   

Abstract

CONTEXT: The data on histological and receptor status in breast cancer in an Indian population is limited as receptor status is not routinely carried out for these patients. In the present study, receptor status was analyzed and it was correlated with morphological prognostic parameters.
OBJECTIVE: To analyze the morphological prognostic parameters and its correlation with receptor status in Indian women.
DESIGN: The sample consisted of 126 specimens of invasive breast cancer received in department of pathology of our institution with teaching hospital attached to it, situated in South Canara district of, Karnataka, South India between year 2009 and 2011. RESULT: Sixty-seven percent of patients were 50 years or younger. Histological types were invasive ductal carcinoma, not otherwise specified (58.7%), and overall (15.9%) were grade 3. Estrogen receptor was positive in 36.5%, HER/neu was overexpressed in only three cases; 50.0% were "triple" negative (estrogen receptor, progesterone receptor, HER/neu negative). Estrogen receptor (ER) and progesterone receptor (PR) positivity decreased with increase in tumor grade. There was significant association between tumor size and ER positivity.
CONCLUSIONS: Breast carcinoma in our population presents at younger age than Western population. Our results showed very high proportion of triple-negative breast cancers. The tumor size and grade is related to expression of only ER. The findings suggest that women in our population more often have histologically aggressive breast carcinoma at young age, likely to be less susceptible to conventional hormonal and targeted antibody treatment. Detecting and treating this increasing important cause of mortality will be an enormous challenge.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23575073     DOI: 10.4103/0973-1482.110358

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  10 in total

1.  Distinct breast cancer subtypes in women with early-onset disease across races.

Authors:  Mandeep Singh; Yi Ding; Li-Ying Zhang; Dong Song; Yun Gong; Sylvia Adams; Dara S Ross; Jin-Hua Wang; Shruti Grover; Dinesh Chandra Doval; Charles Shao; Zi-Li He; Victor Chang; Warren W Chin; Fang-Ming Deng; Baljit Singh; David Zhang; Ru-Liang Xu; Peng Lee
Journal:  Am J Cancer Res       Date:  2014-07-16       Impact factor: 6.166

Review 2.  Prevalence of Molecular Subtypes of Breast Cancer in India: a Systematic Review and Meta-analysis.

Authors:  Pavan Kumar Jonnada; Cherukuru Sushma; Madhuri Karyampudi; Anvesh Dharanikota
Journal:  Indian J Surg Oncol       Date:  2020-10-28

Review 3.  Improving accuracy of breast cancer biomarker testing in India.

Authors:  Tanuja Shet
Journal:  Indian J Med Res       Date:  2017-10       Impact factor: 2.375

Review 4.  Prevalence of Triple-Negative Breast Cancer in India: Systematic Review and Meta-Analysis.

Authors:  Gurprataap S Sandhu; Sebhat Erqou; Heidi Patterson; Aju Mathew
Journal:  J Glob Oncol       Date:  2016-06-29

5.  Meta-Analysis of Prevalence of Triple-Negative Breast Cancer and Its Clinical Features at Incidence in Indian Patients With Breast Cancer.

Authors:  Apurv Kulkarni; Devaki A Kelkar; Nidhi Parikh; Lingadahalli S Shashidhara; Chaitanyanand B Koppiker; Madhura Kulkarni
Journal:  JCO Glob Oncol       Date:  2020-07

6.  Hormonal Receptors, Human Epidermal Growth Factor Receptor-2 and Triple Negative Immunohistochemical Typing in Women with Breast Cancer in Kampala, Uganda.

Authors:  Angela T Mlole; James J Yahaya; Emmanuel Othieno; Sam Kalungi; Andrew L Okwi
Journal:  Int J Womens Health       Date:  2020-11-27

7.  Immunohistochemical Markers in Breast Cancer: A Cross-Sectional Study on Triple-Negative Breast Cancer in a Rural Tertiary Care Hospital.

Authors:  Rakesh Ba; Venkata Pavan Kumar Karanam; Ashishkumar B Mundada
Journal:  Cureus       Date:  2021-11-11

8.  Expression of p53 and p16 in Carcinoma Breast Tissue: Depicts Prognostic Significance or Coincidence.

Authors:  Manjit K Rana; Amrit Pal S Rana; Utkarshni Khera
Journal:  Cureus       Date:  2021-11-09

9.  Prospective Evaluation of Response Outcomes of Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer.

Authors:  Ashok A; Nandkishor Sopanrao Sude; Rakesh B A; Venkata Pavan Kumar Karanam
Journal:  Cureus       Date:  2022-02-02

10.  Breast carcinoma in young females below the age of 40 years: A histopathological perspective.

Authors:  Shitalmala Thangjam; Rajesh Singh Laishram; Kaushik Debnath
Journal:  South Asian J Cancer       Date:  2014-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.